Stocks
Bluebird Bio (BLUE) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -1 730% | -220.8% | -15 208% | -5 993% | -566.7% | -241.4% | ||
| Changes by years, y/y, % | -693pp | +1 509pp | -14 987pp | +9 216pp | +5 426pp | -11.4% | |||
Bluebird Bio. EBITDA margin, %
Bluebird Bio. EBITDA margin, changes, pp
Bluebird Bio (BLUE) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q3 | 2024Q1 | 2023Q4 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -683.7% | -266.4% | 260.2% | -368.9% | -374.5% | -241.4% | |
| Changes by years, y/y, % | +123 512pp | +3 282pp | -40 764pp | +584pp | +309pp | |||
| Changes by quarters, q/q, % | +269pp | +417pp | +527pp | -629pp | -6pp | |||
